Micro Cap Growth Fund
Daily price w/o sales charge as of 12/05/2025
$24.72
$0.26
YTD Returns w/o sales charge as of 12/05/2025
13.46%
Overall Morningstar RatingsSmall Growth
as of 11/30/2025
Morningstar rated the Lord Abbett Micro Cap Growth Fund class I share 4, 3 and 4 stars among 524, 502 and 394 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 11/30/2025, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 10/31/2025
- Total Net Assets
- $207.20 M
- Inception Date
- 07/09/1999
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.13%
- Fund Net Expense Ratio
- 1.13%
- Number of Holdings
- 78
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 15.51% | 9.77% | 14.24% | 5.42% | 14.47% | 11.58% |
| Lipper Category Avg. Small-Cap Growth Funds | 9.61% | 1.43% | 11.39% | 4.51% | 9.85% | - |
| Russell Microcap® Growth Index | 22.58% | 17.34% | 16.03% | 4.57% | 7.23% | - |
| w/ sales charge | 15.51% | 9.77% | 14.24% | 5.42% | 14.47% | 11.58% |
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 8.49% | 19.64% | 14.35% | 8.07% | 14.24% | 11.39% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.12% | 7.59% | 14.09% | 6.85% | 10.28% | - |
| Russell Microcap® Growth Index | 19.29% | 33.07% | 17.68% | 7.83% | 8.09% | - |
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 10/31/2025View Portfolio
| Holding | Assets |
|---|---|
| Argan Inc | 3.1% |
| Adaptive Biotechnologies Corp | 2.9% |
| Tarsus Pharmaceuticals Inc | 2.8% |
| Centrus Energy Corp | 2.8% |
| Applied Digital Corp | 2.8% |
| Terawulf Inc | 2.4% |
| Rhythm Pharmaceuticals Inc | 2.3% |
| Mirum Pharmaceuticals Inc | 2.3% |
| Primoris Services Corp | 2.2% |
| GeneDx Holdings Corp | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 10/31/2025View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 15.51% | 9.77% | 14.24% | 5.42% | 14.47% | 11.58% |
| Lipper Category Avg. Small-Cap Growth Funds | 9.61% | 1.43% | 11.39% | 4.51% | 9.85% | - |
| Russell Microcap® Growth Index | 22.58% | 17.34% | 16.03% | 4.57% | 7.23% | - |
| w/ sales charge | 15.51% | 9.77% | 14.24% | 5.42% | 14.47% | 11.58% |
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/09/1999 |
|---|
| w/o sales charge | 8.49% | 19.64% | 14.35% | 8.07% | 14.24% | 11.39% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.12% | 7.59% | 14.09% | 6.85% | 10.28% | - |
| Russell Microcap® Growth Index | 19.29% | 33.07% | 17.68% | 7.83% | 8.09% | - |
Fund Expense Ratio :
Gross 1.13%
Net 1.13%
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2024 | 27.28% | 21.91% |
| 2023 | 6.14% | 9.11% |
| 2022 | -29.10% | -29.76% |
| 2021 | 3.74% | 0.88% |
| 2020 | 79.62% | 40.13% |
| 2019 | 34.56% | 23.33% |
| 2018 | 2.85% | -14.18% |
| 2017 | 38.38% | 16.65% |
| 2016 | 2.05% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.84% | - |
| 2013 | 78.60% | - |
| 2012 | 2.61% | - |
| 2011 | -5.68% | - |
| 2010 | 34.16% | - |
| 2009 | 52.94% | - |
| 2008 | -46.28% | - |
| 2007 | 23.03% | - |
| 2006 | 25.71% | - |
| 2005 | 2.81% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2025 | -17.85% | 15.92% | 13.93% | - |
| 2024 | 7.71% | 0.22% | 6.93% | 10.27% |
| 2023 | 5.64% | 4.23% | -13.40% | 11.31% |
| 2022 | -17.19% | -22.51% | 8.29% | 2.02% |
| 2021 | 12.36% | -0.04% | -9.38% | 1.93% |
| 2020 | -24.27% | 47.66% | 17.49% | 36.72% |
| 2019 | 22.62% | 7.46% | -13.89% | 18.59% |
| 2018 | 5.33% | 15.78% | 10.04% | -23.35% |
| 2017 | 8.97% | 8.17% | 13.63% | 3.32% |
| 2016 | -13.66% | 5.93% | 14.56% | -2.61% |
| 2015 | 7.34% | 4.13% | -16.29% | 0.06% |
| 2014 | 7.88% | -6.49% | -6.59% | 17.62% |
| 2013 | 21.81% | 15.05% | 17.29% | 8.65% |
| 2012 | 17.75% | -9.67% | 1.33% | -4.80% |
| 2011 | 4.83% | 0.21% | -21.88% | 14.92% |
| 2010 | 6.71% | -8.76% | 15.18% | 19.64% |
| 2009 | -0.92% | 31.55% | 13.54% | 3.35% |
| 2008 | -23.11% | 4.51% | -5.94% | -28.93% |
| 2007 | 5.67% | 9.88% | 4.11% | 1.78% |
| 2006 | 17.21% | -9.74% | 1.27% | 17.34% |
| 2005 | -9.47% | 5.97% | 6.97% | 0.18% |
| 2004 | 12.41% | 1.71% | -11.01% | 24.04% |
| 2003 | -3.40% | 27.24% | 11.82% | 8.95% |
| 2002 | 0.00% | -12.70% | -21.73% | 1.46% |
| 2001 | 2.44% | 12.12% | -20.98% | 29.33% |
| 2000 | 26.57% | -20.89% | -4.70% | -19.21% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Argan Inc | Industrials | 3.1% |
| Adaptive Biotechnologies Corp | Health Care | 2.9% |
| Tarsus Pharmaceuticals Inc | Health Care | 2.8% |
| Centrus Energy Corp | Energy | 2.8% |
| Applied Digital Corp | Information Technology | 2.8% |
| Terawulf Inc | Information Technology | 2.4% |
| Rhythm Pharmaceuticals Inc | Health Care | 2.3% |
| Mirum Pharmaceuticals Inc | Health Care | 2.3% |
| Primoris Services Corp | Industrials | 2.2% |
| GeneDx Holdings Corp | Health Care | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Argan Inc | Industrials | 3.1% |
| Adaptive Biotechnologies Corp | Health Care | 2.9% |
| Tarsus Pharmaceuticals Inc | Health Care | 2.8% |
| Centrus Energy Corp | Energy | 2.8% |
| Applied Digital Corp | Information Technology | 2.8% |
| Terawulf Inc | Information Technology | 2.4% |
| Rhythm Pharmaceuticals Inc | Health Care | 2.3% |
| Mirum Pharmaceuticals Inc | Health Care | 2.3% |
| Primoris Services Corp | Industrials | 2.2% |
| GeneDx Holdings Corp | Health Care | 2.2% |
| Cidara Therapeutics Inc | Health Care | 2.2% |
| Artivion Inc | Health Care | 2.2% |
| Calix Inc | Information Technology | 2.1% |
| uniQure NV | Health Care | 2.0% |
| Willdan Group Inc | Industrials | 1.9% |
| Pattern Group Inc | Consumer Discretionary | 1.9% |
| Sterling Infrastructure Inc | Industrials | 1.8% |
| Life360 Inc | Information Technology | 1.8% |
| OSI Systems Inc | Information Technology | 1.7% |
| Arlo Technologies Inc | Information Technology | 1.7% |
| Beta Bionics Inc | Health Care | 1.7% |
| Agilysys Inc | Information Technology | 1.6% |
| Mercury Systems Inc | Industrials | 1.6% |
| TAT Technologies Ltd | Industrials | 1.6% |
| Celcuity Inc | Health Care | 1.6% |
| Paymentus Holdings Inc | Financials | 1.5% |
| VSE Corp | Industrials | 1.5% |
| Powell Industries Inc | Industrials | 1.4% |
| Ouster Inc | Information Technology | 1.3% |
| Bel Fuse Inc | Information Technology | 1.3% |
| Arcellx Inc | Health Care | 1.3% |
| Piper Sandler Cos | Financials | 1.3% |
| Dave Inc | Financials | 1.3% |
| Standex International Corp | Industrials | 1.3% |
| Vita Coco Co Inc/The | Consumer Staples | 1.2% |
| PTC Therapeutics Inc | Health Care | 1.2% |
| Huron Consulting Group Inc | Industrials | 1.2% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.2% |
| CECO Environmental Corp | Industrials | 1.2% |
| Limbach Holdings Inc | Industrials | 1.2% |
| Omada Health Inc | Health Care | 1.1% |
| HeartFlow Inc | Health Care | 1.1% |
| BlackSky Technology Inc | Industrials | 1.0% |
| Legence Corp | Industrials | 1.0% |
| TransMedics Group Inc | Health Care | 0.9% |
| Ambarella Inc | Information Technology | 0.9% |
| ThredUp Inc | Consumer Discretionary | 0.9% |
| Xometry Inc | Industrials | 0.9% |
| Praxis Precision Medicines Inc | Health Care | 0.9% |
| Miami International Holdings Inc | Financials | 0.9% |
| nLight Inc | Information Technology | 0.8% |
| Hawkins Inc | Materials | 0.8% |
| Gilat Satellite Networks Ltd | Information Technology | 0.8% |
| Newamsterdam Pharma Co NV | Health Care | 0.8% |
| Cogent Biosciences Inc | Health Care | 0.8% |
| Kestra Medical Technologies Ltd | Health Care | 0.7% |
| Red Violet Inc | Information Technology | 0.7% |
| Mineralys Therapeutics Inc | Health Care | 0.7% |
| Genius Sports Ltd | Consumer Discretionary | 0.7% |
| Travere Therapeutics Inc | Health Care | 0.7% |
| Oddity Tech Ltd | Consumer Staples | 0.7% |
| D-Wave Quantum Inc | Information Technology | 0.6% |
| IMAX Corp | Communication Services | 0.6% |
| Hinge Health Inc | Health Care | 0.6% |
| Lincoln Educational Services Corp | Consumer Discretionary | 0.6% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 0.6% |
| Soleno Therapeutics Inc | Health Care | 0.6% |
| Sphere Entertainment Co | Communication Services | 0.6% |
| Vital Farms Inc | Consumer Staples | 0.5% |
| ORIC Pharmaceuticals Inc | Health Care | 0.5% |
| MNTN Inc | Communication Services | 0.5% |
| Chefs' Warehouse Inc/The | Consumer Staples | 0.5% |
| LENZ Therapeutics Inc | Health Care | 0.5% |
| Warby Parker Inc | Consumer Discretionary | 0.4% |
| American Public Education Inc | Consumer Discretionary | 0.4% |
| Neptune Insurance Holdings Inc | Financials | 0.4% |
| Innodata Inc | Industrials | 0.4% |
| Black Rock Coffee Bar Inc | Consumer Discretionary | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 10/31/2025
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
1.1%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.6%
|
|
| Consumer Staples |
2.6%
|
|
| Energy |
 0.3%
|
|
| Financials |
0.1%
|
|
| Health Care |
6.0%
|
|
| Industrials |
1.2%
|
|
| Information Technology |
0.5%
|
|
| Materials |
0.5%
|
Portfolio Details as of 10/31/2025
- Total Net Assets
- $207.20 M
- Number of Holdings
- 78
- Weighted Average Market Cap.
- 3.7 B
- P/B Ratio
- 8.0x
- P/E Ratio
- 37.5x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 12/05/2025
- $0.00190
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 12/01/2025 | 12/02/2025 | 12/02/2025 | $0.00190 | $24.36 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $18.90 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Expense Ratioas of 11/30/2025
| Fund Gross Expense Ratio | 1.13% |
| Fund Net Expense Ratio | 1.13% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2024 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2025 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|